ScholarGPS™ named Thomas Lodise, PharmD, PhD, to the top of their list, Highly Ranked Scholar – Prior 5 Years, for his publications on vancomycin. Authors who make the list of Highly Ranked Scholars™ must maintain high measures of publications, quality, and impact that place them at the top 0.05% or better of all scholar profiles on the platform. Reflecting on this significant achievement, Dr. Lodise said, “This was due, in larger part, to PROVIDE. I appreciate ARLG for supporting this study; it changed practice. It was a pleasure working with the team on the study. It was an incredible collaborative effort.”

Dr. Lodise is the Pharmacokinetic Lead for ARLG and protocol PI on the OPTIMIZE-GNI study. He also shares his expertise as a member of several ARLG committees. View Dr. Lodise’s ScholarGPS profile to learn more about his vital work in antibiotic medications.

Please join us in extending our heartfelt gratitude to Deborah Hopkins, MA, AAS, CMA (AAMA), CCT, for 10 years of dedication to ARLG research at Duke Clinical Research Institute (DCRI). In July, Deborah retired from her role as a Clinical Trials Coordinator II where she provided vital study team, site management, monitoring, and regulatory support. From study start-up through close-out, her contributions have made a valuable impact on countless research projects over the past decade. In that time, she has collaborated to share her knowledge and expertise with study teams across the U.S. and in countries around the world including China, Israel, and Spain.

Looking back over her career, Deborah is proud of her commitment to ARLG’s mission and considers every study she worked on to be significant. “I believe in the sharing of knowledge across the globe and improving health care for everyone,” she states.

In retirement, Deborah looks forward to visiting the beach and mountains and spending more time with her family and grandchildren. She also plans to continue sharing her knowledge with others by volunteering as a teacher and pursuing her PhD in theology.

For nearly three decades, Brenda Mickley has been a cornerstone of grant administration at Duke Clinical Research Institute (DCRI), bringing expertise, strategic insight, and unwavering commitment to advancing public health. She played a pivotal role in shaping and supporting major research initiatives as part of her role with Grants & Proposal Services.

Brenda’s journey with ARLG began at its inception. She collaborated closely with the team on the original application that launched the program and helped to lay the foundation for ARLG. From there, Brenda was instrumental in the competitive renewal process, ensuring the continuity and growth of ARLG’s mission.

In recognition of her 29 years of service, Brenda received the Rob Califf Excellence in Service Award from the DCRI to honor her achievements and support of programs designed to improve health around the world. The ARLG extends its heartfelt gratitude to Brenda for her valuable contributions over the years. We wish her a well-deserved and enjoyable retirement.